EC Number   |
Application |
Reference |
|---|
   3.4.24.B3 | diagnostics |
association between the clinicopathological characteristics and MMP-11 expression in oral squamous cell carcinoma (OSCC) patients, expression of MMP-11 is associated with higher incidence of lymph node metastasis and worse grade of tumor differentiation, overview. The MMP-11 expression in OSCC samples can predict the progression, especially lymph node metastasis, and the survival of OSCC patients in Taiwan |
754962 |
| 3.4.24.B3 | diagnostics |
matrix metalloproteinase 11 is a marker for advanced gastric cancer |
708668 |
| 3.4.24.B3 | diagnostics |
MMP-11 is a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry |
752463 |
| 3.4.24.B3 | diagnostics |
MMP-11 is a probable prognostic marker whose expression reflects the stages of tumor differentiation and lymph node metastasis of breast cancer, overview |
708173 |
| 3.4.24.B3 | diagnostics |
MMP-11 may work as a significant tumor biomarker for early detection of cancer, tumor staging, prognostic analysis, monitoring recurrence during follow-up and also a potential target for immunotherapy against cancer. Prognostic significance of MMP-11 expression in gastric carcinoma. The 5-year survival rates of patients with high expression of both MMP-11 and IGF-1 is significantly lower compared to the patients with low expression levels of both MMP-11 and IGF-1. Expression of MMP-11 and VEGF-C in colorectal adenocarcinoma is believed to be an important index for predicting distant metastases and clinical stages. MMP-11 is not only correlated with advanced-stage and high-grade tumors, but significantly associated with metastasis, especially for lymph node metastasis rather than peritoneal seeding and distant organ metastasis. The expression levels of MMP-11 can be used to identify patients at greater risk for cancer recurrence in breast carcinoma, pancreatic tumors, and colon cancer |
753930 |
| 3.4.24.B3 | diagnostics |
MMP11 expression is a poor prognosis factor in human carcinomas |
-, 708766 |
| 3.4.24.B3 | medicine |
being selectively expressed in tumor tissues, MMP-11 is a promising target for immunotherapy against tumors |
753043 |
| 3.4.24.B3 | medicine |
enzyme MMP-11 is an antigen target for immunotherapy |
753930 |
| 3.4.24.B3 | medicine |
MMP11 expression level is correlated with poor prognosis in advanced gastric cancer. MMP11 has great potential to be a new tumor marker in serum |
691858 |
| 3.4.24.B3 | medicine |
MMP11 is a novel broadly expressed tumor associated antigen and a target candidate for cancer immunotherapy. Possible use of murine MMP11 as tumor-associated antigen for vaccination of human cancer patients. MMP11 vaccine induces cell-mediated and antibody immune response and exerts significant antitumoral protection in mice with colon cancer in prophylactic and therapeutic settings |
-, 708156 |
